China Pharma Holdings (CPHI) Enterprise Value (2010 - 2026)
China Pharma Holdings (CPHI) reported Enterprise Value of -$168474.0 for Q1 2026, up 59.18% on a YoY basis from -$105841.1 in Q1 2025, and up 51.18% quarter-over-quarter from -$345112.0 in Q4 2025.
China Pharma Holdings (CPHI) Enterprise Value (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Enterprise Value for 17 years, with the latest figure at -$168474.0 in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 59.18% year-over-year to -$168474.0; the trailing twelve-month figure through Mar 2026 stood at -$168474.0 (up 59.18% YoY), and the FY2025 full-year result was -$345112.0, up 44.95% from the prior year.
- Enterprise Value for Q1 2026 stood at -$168474.0, up from -$345112.0 in the prior quarter.
- The five-year high for Enterprise Value was -$168474.0 in Q1 2026, with the low at -$3.7 million in Q1 2022.
- Historically, Enterprise Value has averaged -$1.2 million across 5 years, with a median of -$838881.0 in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 640.0% — and 2023, when it surged 68.46%.
- China Pharma Holdings' Enterprise Value stood at -$2.0 million in 2022, then increased by 29.86% to -$1.4 million in 2023, then soared by 55.97% to -$626879.0 in 2024, then surged by 44.95% to -$345112.0 in 2025, then surged by 51.18% to -$168474.0 in 2026.
- The last three Enterprise Value figures came in at -$168474.0 (Q1 2026), -$345112.0 (Q4 2025), and -$300000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -498.58 Mn |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | -168,474.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168,474.00 |
| Dec 31, 2025 | -345,112.00 |
| Sep 30, 2025 | -300,000.00 |
| Jun 30, 2025 | -625,032.00 |
| Mar 31, 2025 | -412,688.00 |
| Dec 31, 2024 | -626,879.00 |
| Sep 30, 2024 | -718,691.00 |
| Jun 30, 2024 | -739,337.00 |
| Mar 31, 2024 | -838,881.00 |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -1.37 Mn |
| Jun 30, 2023 | -901,910.00 |
| Mar 31, 2023 | -1.17 Mn |
| Dec 31, 2022 | -2.03 Mn |
| Sep 30, 2022 | -2.10 Mn |
| Jun 30, 2022 | -2.24 Mn |
| Mar 31, 2022 | -3.70 Mn |
| Dec 31, 2021 | -4.86 Mn |
| Sep 30, 2021 | -458,831.00 |
| Jun 30, 2021 | -1.75 Mn |